ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...
Euro Lost 0.29% to $1.0393 — Data Talk
Month-to-date it is up 0.36% vs the dollar --Year-to-date the euro is up 0.36% vs the dollar ...